Literature DB >> 12018456

Preoperative radiation with or without chemotherapy and full-thickness transanal excision for selected T2 and T3 distal rectal cancers.

L Ruo1, J G Guillem, B D Minsky, S H Q Quan, P B Paty, A M Cohen.   

Abstract

BACKGROUND AND AIMS: To evaluate the clinical outcome of selected patients with distal rectal cancer treated by preoperative radiation with or without chemotherapy and full-thickness local excision (FTLE). PATIENTS AND METHODS: Ten patients with invasive distal rectal cancer (six T2, four T3) were treated with preoperative radiotherapy (3600-5040 cGy) with or without 5-fluorouracil based chemotherapy. FTLE was performed 4-6 weeks after completion of radiotherapy, primarily because of comorbid diseases or patient refusal of a permanent colostomy. Median follow-up was 28.5 months.
RESULTS: There were no prolonged wound complications, and only one positive microscopic margin was detected. Among three cases of complete pathological response, two remain without evidence of disease. All patients retained sphincter function and avoided creation of a stoma. Two patients developed recurrence, one with widespread disease including pelvic recurrence 26 months after surgery and the other with distant disease only at 23 months. There were four deaths: two unrelated to cancer, one of undetermined cause after 7 years, and one after widespread recurrence at 26 months, with death 4 months later. Two-year actuarial survival was 78%.
CONCLUSIONS: This pilot study demonstrates that preoperative radiotherapy and FTLE avoids major abdominal surgery yet facilitates sphincter preservation, excision with negative margins, and short-term local control in selected patients with distal rectal cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12018456     DOI: 10.1007/s003840100327

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  19 in total

1.  Transanal endoscopic microsurgery for 135 patients with small nonadvanced low rectal cancer (iT1-iT2, iN0): short- and long-term results.

Authors:  Giovanni Lezoche; Mario Guerrieri; Maddalena Baldarelli; Alessandro Maria Paganini; Giancarlo D'Ambrosio; Roberto Campagnacci; Silvia Bartolacci; Emanuele Lezoche
Journal:  Surg Endosc       Date:  2010-10-07       Impact factor: 4.584

2.  Prognostic relevant factors within pT3 rectal carcinomas: depth of invasion or circumferrential resection margins?

Authors:  Benno Mann
Journal:  Int J Colorectal Dis       Date:  2003-06-03       Impact factor: 2.571

3.  A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial.

Authors:  Julio Garcia-Aguilar; Qian Shi; Charles R Thomas; Emily Chan; Peter Cataldo; Jorge Marcet; David Medich; Alessio Pigazzi; Samuel Oommen; Mitchell C Posner
Journal:  Ann Surg Oncol       Date:  2011-07-14       Impact factor: 5.344

4.  Increased spontaneous apoptosis, but not survivin expression, is associated with histomorphologic response to neoadjuvant chemoradiation in rectal cancer.

Authors:  Dermot T McDowell; Fraser M Smith; John V Reynolds; Stephen G Maher; Collette Adida; Paul Crotty; Eoin F Gaffney; Donal Hollywood; Brian Mehigan; Richard B Stephens; M J Kennedy
Journal:  Int J Colorectal Dis       Date:  2009-07-11       Impact factor: 2.571

5.  [Present treatment strategies for rectal carcinoma].

Authors:  T Liersch; C Langer; B M Ghadimi; H Becker
Journal:  Chirurg       Date:  2005-03       Impact factor: 0.955

6.  p27 expression in post-treatment rectal cancer: a potential novel approach for predicting residual nodal disease.

Authors:  Tobias Leibold; Vanessa W Hui; Jinru Shia; Jeannine A Ruby; Elyn R Riedel; José G Guillem
Journal:  Am J Surg       Date:  2014-04-13       Impact factor: 2.565

7.  Long-term results of transanal excision after neoadjuvant chemoradiation for T2 and T3 adenocarcinomas of the rectum.

Authors:  Rajesh M Nair; Erin M Siegel; Dung-Tsa Chen; William J Fulp; Timothy J Yeatman; Mokenge P Malafa; Jorge Marcet; David Shibata
Journal:  J Gastrointest Surg       Date:  2008-08-15       Impact factor: 3.452

8.  Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer.

Authors:  Glenda G Callender; Prajnan Das; Miguel A Rodriguez-Bigas; John M Skibber; Christopher H Crane; Sunil Krishnan; Marc E Delclos; Barry W Feig
Journal:  Ann Surg Oncol       Date:  2009-10-22       Impact factor: 5.344

9.  Transanal local excision for preoperative concurrent chemoradiation therapy for distal rectal cancer in selected patients.

Authors:  Chimin Park; Wooyong Lee; Sangah Han; Seonghyeon Yun; Ho-Kyung Chun
Journal:  Surg Today       Date:  2007-11-26       Impact factor: 2.549

Review 10.  Risk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancers.

Authors:  Jia-Yuan Peng; Zhong-Nan Li; Yu Wang
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.